These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats. Straight TM; Ottolini MG; Prince GA; Eichelberger MC Virol J; 2008 Mar; 5():44. PubMed ID: 18355405 [TBL] [Abstract][Full Text] [Related]
12. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy. Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631 [TBL] [Abstract][Full Text] [Related]
13. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses. Choi A; Ibañez LI; Strohmeier S; Krammer F; García-Sastre A; Schotsaert M Front Immunol; 2020; 11():1166. PubMed ID: 32582220 [TBL] [Abstract][Full Text] [Related]
14. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration. Budimir N; de Haan A; Meijerhof T; Gostick E; Price DA; Huckriede A; Wilschut J Influenza Other Respir Viruses; 2013 Nov; 7(6):1202-9. PubMed ID: 24102979 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial. Eiden J; Fierro C; White A; Davis M; Rhee M; Turner M; Murray B; Herber R; Aitchison R; Marshall D; Moser MJ; Belshe R; Greenberg H; Coelingh K; Kawaoka Y; Neumann G; Bilsel P Lancet Infect Dis; 2024 Oct; 24(10):1118-1129. PubMed ID: 39004096 [TBL] [Abstract][Full Text] [Related]
16. Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults. Eiden J; Gordon G; Fierro C; Herber R; Aitchison R; Belshe R; Greenberg H; Hoft D; Hatta Y; Moser MJ; Tary-Lehmann M; Kawaoka Y; Neumann G; Radspinner P; Bilsel P Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960134 [TBL] [Abstract][Full Text] [Related]